Urologic Oncology is dedicated to the coverage of all aspects of cancers of the genitourinary system. The journal will publish original research papers from the laboratory and the clinic, review articles, and discussions of controversies. Physicians and scientists alike should find both practical and provocative reading in topics ranging from genetics and cell biology, newly developed diagnostic techniques, and changing approaches to treatment in the broad field of urologic oncology. The target audience is international and multidisciplinary, and is designed to include urologists, medical oncologists, radiation oncologists, pathologists, cell and molecular biologists, geneticists and any clinician or investigator working in or having an interest in this field. The journal's major objective is to stimulate new ideas and research with a multidisciplinary base in both the laboratory and in the clinic of the various problems in oncology that affect the genitourinary system.